With the recent announcement of the USAID/Janssen Bdq Donation Program, there is now an opportunity for increased access to this new tool for the treatment of drug-resistant tuberculosis. This webinar will review the 5 conditions, specified by the WHO in their interim policy guidelines, with practical guidance for helping countries and programs introduce bedaquiline in an optimal way.
Speaker: Dr. Jennifer Furin
This webinar is free but requires registration here.
For more information, click here.